Previcox

Țară: Noua Zeelandă

Limbă: engleză

Sursă: Ministry for Primary Industries

Ingredient activ:

firocoxib

Disponibil de la:

Boehringer Ingelheim Animal Health New Zealand Limited

INN (nume internaţional):

firocoxib

Compoziție:

firocoxib 240 g/kg

Zonă Terapeutică:

Analgesic

Statutul autorizaţiei:

ACVM Registered

Data de autorizare:

2005-01-31

Caracteristicilor produsului

Product: Previcox - 57 mg
Date: 24 Nov 2022
ACVM No.: A009342
Page 1 of 14
BOTTLE LABEL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS
FOR ANIMAL TREATMENT ONLY
PREVICOX
®
57 MG HI-SELECT COX-2 FLAVOURED TABLETS: PAIN & INFLAMMATION CONTROL
FOR DOGS
EACH TABLET CONTAINS 57 MG FIROCOXIB
A highly selective COX-2 inhibitor for relief of pain and control of
inflammation associated with
osteoarthritis and other musculo-skeletal disorders. PREVICOX is also
indicated for the control of post-
operative pain associated with surgery; including soft tissue,
orthopaedic and dental procedures.
57 mg
60 tablets
_(BI logo) _
_ _
READ THE LEAFLET FOR FULL INSTRUCTIONS.
Store below 30 °C (Room temperature)
APVMA No: 58093/126349
New Zealand Info: RVM
ACVM No: A009342
Made in France.
[B]:
[E]:
Product: Previcox - 57 mg
Date: 24 Nov 2022
ACVM No.: A009342
Page 2 of 14
CARTON (BOTTLE) LABEL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS
FOR ANIMAL TREATMENT ONLY
PREVICOX
®
57 MG HI-SELECT COX-2 FLAVOURED TABLETS: PAIN & INFLAMMATION CONTROL
FOR DOGS
EACH TABLET CONTAINS 57 MG FIROCOX
IB
57 mg
60 tablets
_(BI logo) _
Product: Previcox - 57 mg
Date: 24 Nov 2022
ACVM No.: A009342
Page 3 of 14
_ _
_ _
_ _
A highly selective COX-2 inhibitor* for relief of pain and control of
inflammation associated with
osteoarthritis and other musculo-skeletal disorders. PREVICOX is also
indicated for the control of post-
operative pain associated with surgery; including soft tissue,
orthopaedic and dental procedures.
*At least 350X selection of COX-2 over COX-1 in _in vitro _canine
blood assays. No COX-1 inhibition _in vitro _at levels observed in
plasma after
therapeutic doses.
READ THE LEAFLET FOR FULL INSTRUCTIONS.
DIRECTIONS FOR USE
CONTRAINDICATIONS
This product should not be used in cats as a dose level for firocoxib
has not been established. This
product should not be used in any dog that has previously exhibited
hypersensitivity to firocoxib.
DOSAGE AND ADMINISTRATION
FOR ORAL